![]() |
市場調查報告書
商品編碼
2026707
全球經皮血管成形術(PTA)球囊市場:市場規模、佔有率和趨勢分析(2025-2032)Percutaneous Transluminal Angioplasty (PTA) Balloon Market Size, Share & Analysis | Global | 2025-2032 | Segmented By Device Type |
||||||
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
全球經皮血管成形術用氣球市場報告
2025年全球經皮血管成形術用氣球市場規模為5.58億美元。在預測期內,該市場預計將以2.5%的複合年成長率成長,到2032年達到約6.63億美元。
本報告重點在於周邊血管介入領域最成熟的醫療設備類別之一-經皮腔內血管成形術(PTA)球囊導管。報告分析了PTA球囊導管的銷售情況,包括銷量、平均售價、手術例數、市場總值、成長率、市場佔有率以及至2032年的預測數據,並納入了截至2022年的歷史數據。此外,報告還分析了市場促進因素和限制因素、近期併購、公司概況、產品系列以及主要競爭對手。 PTA球囊導管市場細分包括標準型、高壓型、大號、小號和特殊用途球囊導管,並按應用領域在多個血管領域進行了進一步的單元分析。
市場概覽
全球經皮血管成形術(PTA)球囊市場包括用於血管內介入治療中擴張狹窄周邊血管的導管球囊。這些裝置是周邊血管介入治療的基礎,廣泛應用於各種動脈和靜脈疾病。在許多手術中,PTA球囊是主要的治療器材。在其他手術中,它們用於支架置入前後,或與斑塊動脈粥狀硬化斑塊切除術、血栓切除術或其他輔助性治療合併使用。
由於其應用範圍極為廣泛,PTA球囊仍然是周邊血管領域最常見的產品類型之一。它們可用於股膕動脈疾病、髂動脈介入治療、膝下手術、頸動脈和腎動脈治療、中心靜脈和血液透析通路以及主動脈應用。這種廣泛的臨床效用確保了該類別產品即使在日益激烈的競爭和價格壓力下也能保持穩定的應用基礎。
該市場的一個關鍵特徵是其成熟度。標準PTA球囊已廣受認可,並由多家競爭對手提供。在許多醫院和臨床機構中,該細分市場的產品選擇很大程度上受價格、供應商關係和更廣泛的產品組合協議的影響。由於這些產品的基本功能已被充分理解,製造商通常透過捆綁銷售和折扣來競爭,而不是進行顯著的產品差異化。
市場促進因素
高血管再阻塞率
PTA球囊導管市場的主要促進因素之一是球囊血管成形術後較高的血管再阻塞率。再血管再阻塞是指血管腔再次變窄,約三分之一接受球囊血管成形術的患者會出現這種情況。這導致需要對同一病變部位進行再次治療,從而支持了球囊導管的長期持續使用。
在許多需要再次治療的病例中,醫生可能會採用更先進的經皮腔內血管成形術(PTA)技術來改善治療效果。諸如球囊導管、切割球囊和冷凍球囊等專用球囊在治療支架內再血管再阻塞和難治性病變方面可以發揮更重要的作用。由於這些器械通常比標準球囊更昂貴,因此即使標準球囊的平均售價(ASP)持續面臨下行壓力,再次治療的趨勢也支撐了它們的市場價值。
小型PTA球囊導管
小型PTA球囊也是重要的成長要素。這些產品使醫生能夠進入更狹窄、更難治療的血管結構,而這些結構不效用使用較大的標準球囊。它們在膝下手術中尤其重要,因為這些手術通常需要直徑較小的器械來到達更遠端的病變部位。
小型球囊的應用範圍遠不止於膝下血管治療。它們通常與其他器械合併使用,特別適用於頸動脈和股動脈介入治療中自動擴張型支架的術前和術後擴張。這種廣泛的效用提升了它們在手術中的重要性,並推動了市場需求的進一步成長。
小型球囊之所以備受關注,另一個原因是它們可以略微縮短患者的恢復時間,並有助於提高治療效率。雖然這並非選擇產品的唯一因素,但它支持了小型球囊的持續臨床應用,尤其是在手術控制和血管通路至關重要的應用中。
POBA手術量增加
傳統球囊血管成形術(POBA)的持續應用也是市場需求的促成因素,尤其是在歐洲。在某些地區,血管外科醫師傾向於先採用球囊擴張而非支架植入的方式進行血管內治療。這種方法可以為未來的治療選擇保留更多可能性,並且可能更符合醫生在無需立即植入永久性植入的病變情況下的偏好。
因此,即使在擁有更先進輔助技術的市場中,PTA球囊仍佔有重要地位。在特定地區推廣以POBA為基礎的治療方法,有助於維持全球手術量,並支撐PTA球囊市場的整體價值。
市場限制
價格下跌
全球PTA氣球市場最大的限制因素是價格下跌。 PTA氣球幾乎已經商品化,尤其是在標準型產品領域。由於眾多廠商提供類似產品,競爭異常激烈,平均售價持續承壓。當供應商將氣球作為更廣泛的產品組合策略的一部分時,這種壓力尤其明顯。
銷售高價動脈粥狀硬化斑塊切除術系統和其他高階血管醫療設備的公司通常會大幅降低球囊的價格,以維持和擴大其在盈利的市場佔有率。這種商品搭售策略使製造商即使在球囊利潤率下降的情況下也能維持整體客戶價值。雖然這種策略在商業性有效,但卻對整個市場的PTA球囊價格造成了持續的下行壓力。
價格下跌趨勢也受到贖回方案重組和標準氣球式債券市場成長潛力相對較低的影響。這些因素共同導致該市場板塊對大規模新投資的吸引力下降。
標準氣球段的商品化
PTA球囊市場不僅受價格限制,也受到標準球囊商品化程度的限制。在許多臨床環境中,標準球囊被認為是可互換或幾乎可互換的。這降低了製造商僅憑功能進行有效差異化的能力,競爭已轉向合約、定價和供應商關係。
因此,標準產品細分市場的平均售價最低,高階定位空間有限。即使銷售穩定,商品同質化也使得供應商難以在市場最成熟的領域實現營收成長。
成熟品類成長潛力低
標準PTA球囊已廣泛應用並廣受認可,限制了其成長潛力。與更具差異化的血管治療技術相比,這也降低了對該領域進一步投資的吸引力。雖然此手術的需求穩定,但其市場成長潛力遠不及專業病變矯正設備和更先進的影像導引治療等成長較快的領域。
這並不意味著PTA球囊市場的重要性正在降低。相反,這意味著未來價值成長可能不僅來自標準產品,還可能來自體積更小、性能更高的特種產品。
市場覆蓋範圍和數據範圍
定量研究範圍
市場規模、市佔率、市場預測、市場成長率、銷售量、平均售價。
定性研究範圍
市場促進因素和阻礙因素、成長趨勢、競爭分析、近期併購、公司簡介、產品系列和主要競爭對手。
目標期
基準年:2025 年,歷史資料截至 2022 年,預測至 2032 年。
區域分析
北美洲、拉丁美洲、西歐、中歐和東歐、中東、亞太地區、非洲。
包含的資料類型
銷售量、平均售價、治療次數、市場規模和成長趨勢。
本報告對 PTA 球囊市場進行了分析,提供了詳細資訊,以支持整個預測期內的定價分析、區域規劃、應用層面策略和競爭基準分析。
目標市場及區隔
標準PTA球囊
這是最成熟、商品化的領域,廣泛應用於常規血管手術。
高壓PTA球囊
當需要更高的破裂壓力來治療難治性病變或解剖結構複雜的病例時,就會使用這種方法。
大型PTA氣球
它適用於較大的血管以及特定的大直徑適應症。
小型PTA氣球
它用於嚴重狹窄和難以進入的血管,例如膝蓋以下的血管和其他複雜的周圍血管。
特製PTA氣球
這包括用於冷凍成形術、切割和刮痕的高附加價值產品,例如球囊。
本報告也包括按應用領域分類的銷售量分析,例如中心靜脈和血液透析通路、股膕動脈通路、髂動脈通路、膕下動脈通路、腎動脈通路、頸動脈通路、主動脈通路及其他手術。每個細分市場均透過市場規模、銷售量和平均售價 (ASP) 進行分析,並預測至 2032 年。
競爭分析
波士頓科學公司是全球PTA球囊導管市場的領導者。該公司憑藉Mustang和Coyote等球囊導管產品,在標準球囊領域建立了強大的產品線。此外,其Flextome切割球囊擴張裝置在特殊PTA球囊領域也佔有重要地位。 2018年收購Cryterion Medical公司,為其技術基礎增添了單次冷凍消融平台,進一步增強了其廣泛的介入產品系列。透過這種方式整合標準產品和特種產品,波士頓科學公司在多個球囊類別中都建立了強大的市場地位。
貝克頓迪金森公司 (BD) 在高壓球囊領域持續發揮著舉足輕重的作用。其「Conquest」系列高壓球囊憑藉著醫生們的大力支持而廣受歡迎,而該公司在該市場中的智慧財產權優勢也發揮著至關重要的作用。擁有與高壓球囊技術相關的專利賦予了 BD 競爭優勢,尤其因為競爭對手的替代設計可能需要增加壁厚或增大輪廓,這可能會損害醫生所青睞的低輪廓特性。 BD 的「Atlas」裝置因其兼具低輪廓和高爆破壓力而特別引人注目,而「Dorado」和「Conquest」平台則正在拓展該公司在高壓應用領域的業務。
美敦力也是主要競爭對手,擁有豐富的產品系列,包括Admiral Extreme、Evercross和Chocolate球囊導管。 「Chocolate」球囊導管的突出之處在於其鎳鈦合金籠狀結構設計,這種設計使擴張更易於控制,並透過減少分離程度來抑制分離。美敦力也透過Rapidcross、Leaf和Amphilion Deep等其他產品保持其市場佔有率,並在PTA球囊市場的多個細分領域擁有廣泛的業務。
總體而言,該市場的競爭格局取決於其廣泛的產品系列的全面性、醫生的認可度、在高壓和專業領域的表現,以及在標準球囊價格大幅折扣的情況下保持競爭力的能力。
科技和醫療治療的發展趨勢
PTA氣球市場最顯著的趨勢之一是標準氣球的持續商品化。雖然這些產品仍然必不可少,但它們面臨巨大的價格壓力,且差異化空間有限。
另一方面,專用PTA球囊仍然具有很高的價值。切割球囊、球囊導管和冷凍成形術裝置可以處理更複雜的病變類型,並且通常比標準產品具有更高的平均售價(ASP)。
此外,小型球囊也變得越來越重要,因為它們擴大了進入解剖結構難以到達區域的通道,並支持膝下和其他遠端血管手術的治療。
高壓球囊在需要更大力量的病灶中仍然很有用,而這一領域繼續受益於醫生對兼具高性能和低輪廓輸送的設備的需求。
從整體市場來看,臨床趨勢表明,球囊擴大作為多種器械聯合應用的手術手段之一,而非在所有病例中都作為獨立工具使用。這凸顯了球囊的重要性,同時也將其商業性價值與更廣泛的血管內治療策略聯繫起來。
地區
本報告提供了涵蓋北美、歐洲、亞太地區、拉丁美洲以及中東和非洲的全球研究成果。
一份長達 87 頁的詳細市場分析、預測和類別層面的洞察報告。
附錄:調查方法和縮寫詞彙表。
儘管價格大幅下降,但全球PTA氣球市場中最具吸引力的機會在哪裡?
小型專業氣球如何改變這個成熟類別中的價值結構?
哪些應用領域和地區將持續支撐穩定的外科手術需求直至 2032 年?
商品化將如何影響定價、競爭和未來的供應商策略?
標準型、高壓型和特殊PTA氣球領域的主要企業有哪些?它們的競爭定位是什麼?
再治療、血管再阻塞治療和輔助使用模式如何支撐長期球囊需求?
iData Research 的《全球經皮血管成形術用氣球市場報告》透過詳細的市場區隔、定價分析、競爭格局資訊和預測模型來解答了這些問題。您可以利用這份報告來評估市場地位、識別高價值細分市場,並在這個成熟但至關重要的血管器械領域制定產業計畫。
圖表清單
調查方法
全球關稅的影響
經皮血管成形術用氣球市場
Global Percutaneous Transluminal Angioplasty Balloon Market Report
The global percutaneous transluminal angioplasty balloon market was valued at $558 million in 2025. Over the forecast period, the market is expected to grow at a CAGR of 2.5% to reach nearly $663 million by 2032.
This report focuses on one of the most established device categories in peripheral vascular intervention. It analyzes PTA balloon catheter sales by unit volume, average selling price, procedure numbers, total market value, growth rates, market shares and forecasts through 2032, with historical data to 2022. It also includes market drivers and limiters, recent mergers and acquisitions, company profiles, product portfolios and analysis of leading competitors. Within the PTA balloon market, segmentation includes standard, high-pressure, large, small and specialty balloon catheters, along with unit analysis by application across multiple vascular territories.
Market Overview
The global PTA balloon market includes catheter-based balloons used to dilate narrowed peripheral vessels during endovascular procedures. These devices are a foundational part of peripheral vascular intervention and are used across a wide range of arterial and venous applications. In many procedures, PTA balloons are the primary treatment device. In others, they are used before or after stent placement, or alongside atherectomy, thrombectomy or other adjunctive therapies.
Because PTA balloons are used so broadly, they remain one of the most familiar product categories in the peripheral vascular space. Their role spans femoral-popliteal disease, iliac interventions, below-the-knee procedures, carotid and renal work, central venous and hemodialysis access and aortic applications. This broad clinical utility gives the category a stable procedural base, even as competition and pricing pressure intensify.
A defining feature of this market is its maturity. Standard PTA balloons are well established and are widely available from multiple competitors. In many hospitals and procedural settings, product selection in this part of the market is influenced heavily by price, vendor relationships and broader portfolio agreements. Because the basic functionality of these products is well understood, manufacturers often compete through bundling and discounting rather than through dramatic product differentiation.
Market Drivers
High Restenosis Rates
One of the main drivers of the PTA balloon catheter market is the high rate of restenosis after balloon angioplasty. Restenosis, which refers to the re-narrowing of the vascular lumen, occurs in roughly one-third of patients who undergo balloon angioplasty. This creates repeat treatment demand at the same lesion site and supports ongoing use of balloon catheters over time.
In many of these repeat cases, physicians may turn to more advanced PTA technologies in order to improve outcomes. Specialty balloons such as scoring balloons, cutting balloons and cryoplasty balloons can play a more important role when treating in-stent restenosis or more resistant lesions. Since these devices typically carry higher prices than standard balloons, repeat treatment patterns can support market value even when standard balloon ASPs remain under pressure.
Small PTA Balloon Catheters
Small PTA balloons are another important growth driver. These products allow physicians to access smaller and more difficult vascular anatomy that would not be suitable for larger standard balloons. Their usefulness in below-the-knee procedures is especially important, as these interventions often require smaller-diameter devices capable of navigating more distal lesions.
Small balloons also support a wide range of procedures beyond below-the-knee treatment. They are frequently used in tandem with other devices and are commonly employed for pre-dilation and post-dilation in procedures involving self-expanding stents, particularly in carotid and femoral-popliteal interventions. This broad utility expands their procedural relevance and supports stronger demand.
Another reason small balloons are attractive is that they can contribute to slightly shorter patient recovery times and more efficient interventions. While this is not the sole driver of product choice, it supports continued clinical use in applications where procedural control and vessel access are especially important.
Increasing POBA Procedures
The continued use of plain old balloon angioplasty, or POBA, is also helping support market demand, particularly in Europe. In some regions, vascular surgeons prefer to begin endovascular treatment with balloon deployment rather than stenting. This approach preserves future treatment options and can align with physician preference in lesion sets where permanent implants are not immediately necessary.
As a result, PTA balloons retain an important role even in markets with access to more advanced adjunctive technologies. The persistence of POBA-based treatment in certain regions helps maintain global procedure volumes and supports the overall value of the PTA balloon market.
Market Limiters
Price Erosion
The strongest limiter in the global PTA balloon market is price erosion. PTA balloons are largely commoditized products, especially in the standard segment. Because many manufacturers offer similar products, competition is intense and average selling prices remain under pressure. This is especially true when vendors use balloons as part of a larger portfolio strategy.
Companies that market higher-priced atherectomy systems or other premium vascular devices often significantly discount their balloons in order to protect or grow their share in more profitable categories. This bundling strategy allows manufacturers to maintain overall account value even if balloon margins decline. While commercially effective, it places sustained downward pressure on PTA balloon pricing across the market.
Downward pricing trends are also influenced by reimbursement restructuring and the relatively low growth potential of the standard balloon segment. Together, these factors make that portion of the market less attractive for major new investment.
Commoditization of the Standard Balloon Segment
The PTA balloon market is not limited by price alone. It is also limited by the degree of commoditization in standard balloons. In many procedural settings, standard balloons are viewed as interchangeable or near-interchangeable products. This reduces the ability of manufacturers to differentiate meaningfully on features alone and shifts competition toward contracts, pricing and supplier relationships.
As a result, the standard segment has the lowest ASP and limited room for premium positioning. Even if unit volumes remain stable, commoditization makes it harder for suppliers to drive revenue growth in the most mature part of the market.
Low Growth Potential in Mature Categories
Because standard PTA balloons are already widely used and well established, their growth potential is modest. This limits the appeal of the category for further investment compared with more differentiated vascular technologies. While procedure need remains steady, the market does not offer the same upside as faster-growing areas such as specialty lesion modification devices or more advanced imaging-guided therapy categories.
This does not mean the PTA balloon market is shrinking in relevance. It means future value growth is likely to come from smaller, high-performance and specialty products rather than from the standard segment alone.
Market Coverage and Data Scope
Quantitative Coverage
Market size, market shares, market forecasts, market growth rates, units sold and average selling prices.
Qualitative Coverage
Market drivers and limiters, growth trends, competitive analysis, recent mergers and acquisitions, company profiles, product portfolios and leading competitors.
Time Frame
Base year 2025, historical data to 2022 and forecasts through 2032.
Regional Coverage
North America, Latin America, Western Europe, Central and Eastern Europe, the Middle East, Asia-Pacific and Africa.
Data Types Included
Unit sales, average selling prices, procedure numbers, market size and growth trends.
This report provides a focused view of the PTA balloon market with enough detail to support pricing analysis, regional planning, application-level strategy and competitive benchmarking across the forecast period.
Markets Covered and Segmentation
Standard PTA Balloons
The most mature and commoditized segment, widely used across routine vascular procedures.
High-Pressure PTA Balloons
Used where greater burst pressure is needed to treat resistant lesions or challenging anatomy.
Large PTA Balloons
Applied in larger vessels and selected high-diameter indications.
Small PTA Balloons
Used in narrower and harder-to-access vessels, including below-the-knee and other complex peripheral applications.
Specialty PTA Balloons
Includes higher-value products such as cryoplasty, cutting and scoring balloons.
The report also includes unit analysis by application across central venous and hemodialysis access, femoral-popliteal, iliac, infra-popliteal, renal, carotid, aorta and other procedures. Each segment is analyzed through market value, units and ASP, with forecasts through 2032.
Competitive Analysis
Boston Scientific is a major competitor in the global PTA balloon catheter market. The company has established offerings in the standard balloon segment through products such as the Mustang and Coyote balloon catheters. It also holds a strong position in the specialty PTA balloon segment with the Flextome Cutting Balloon Dilatation Device. Its 2018 acquisition of Cryterion Medical expanded its technology base with a single-shot cryoablation platform, reinforcing its broader intervention portfolio. This mix of standard and specialty products supports Boston Scientific's position across several balloon categories.
Becton Dickinson, or BD, remains highly influential in the high-pressure balloon segment. The Conquest high-pressure balloon has remained popular because of strong physician acceptance, and the company's intellectual property position has played an important role in this market. Patent control over high-pressure balloon technology creates a competitive advantage, especially because alternative designs from competitors may require thicker walls and higher profiles, which can reduce the low-profile characteristics physicians often prefer. BD's Atlas device is especially notable for combining a low profile with high burst pressure, while the Dorado and Conquest platforms extend the company's presence across higher-pressure use cases.
Medtronic is another leading competitor, supported by a broad portfolio that includes Admiral Xtreme, Evercross and Chocolate balloon catheters. The Chocolate balloon stands out for its nitinol cage design, which enables more controlled dilation and helps reduce dissection propagation by creating smaller dissections. Medtronic also supports its share through additional offerings such as RapidCross, Reef and Amphirion Deep balloons, giving it broad participation across several subsegments of the PTA balloon market.
Overall, competition in this market is shaped by broad portfolio coverage, physician familiarity, performance in high-pressure and specialty categories and the ability to compete in a pricing environment where standard balloons are heavily discounted.
Technology and Practice Trends
One of the clearest trends in the PTA balloon market is the ongoing commoditization of standard balloons. These products remain essential, but pricing pressure is strong and differentiation is limited.
At the same time, specialty PTA balloons continue to offer stronger value. Cutting balloons, scoring balloons and cryoplasty devices address tougher lesion types and often command higher ASPs than standard products.
Smaller-profile balloons are also becoming more important because they expand access to more difficult anatomy and support treatment in below-the-knee and other distal vascular procedures.
High-pressure balloons remain relevant in lesions where greater force is needed, and this segment continues to benefit from physician demand for devices that combine strong performance with low-profile delivery.
Across the market, practice patterns show that balloons are increasingly used as part of multi-device procedures rather than as stand-alone tools in every case. This reinforces the category's importance but also ties its commercial value to broader endovascular treatment strategy.
Geography
This report provides global coverage across North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa.
87 pages of detailed market analysis, forecasts and category-level discussion.
Methodology Appendix and Acronym Glossary.
Where are the most attractive opportunities in the global PTA balloon market despite strong price erosion?
How are small and specialty balloons changing the value mix within this mature category?
Which applications and regions continue to support stable procedure demand through 2032?
How does commoditization affect pricing, competition and future supplier strategy?
Which companies lead in standard, high-pressure and specialty PTA balloons, and how are they positioned competitively?
How do repeat procedures, restenosis treatment and adjunctive use patterns support long-term balloon demand?
The Global Percutaneous Transluminal Angioplasty Balloon Market Report from iData Research answers these questions with detailed segmentation, pricing analysis, competitive intelligence and forecast modeling. Use it to benchmark market position, identify higher-value subsegments and support commercial planning in a mature but essential vascular device category.
List Of Figures
List Of Charts
Research Methodology
Impact Of Global Tariffs
Percutaneous Transluminal Angioplasty Balloon Market